Cedars-Sinai’s IBD Drug Development and Discovery Unit is not a fee-for-service group. Our unit currently maintains relationships with several biotechnology and/or pharmaceutical companies to combine resources and expertise toward the development of new therapeutics in the treatment of Inflammatory Bowel Disease.

Our goal is to collaborate with industry partners in programs anywhere from early discovery to proof-of-concept (POC) trials.

Have Questions or Need Help?

Contact us if you have questions, or wish to learn more about the IBD Drug Discovery and Development Unit at Cedars-Sinai.

8700 Beverly Blvd., Davis Building
Office: D4011 Lab: D4007
Los Angeles, CA 90048

Dermot McGovern, MD, PhD, FRCP
Janine Bilsborough, PhD